BioCardia (BCDA) FCF Margin Growth (1y) (2012 - 2024)
Powered by 
Analysis
BioCardia (BCDA) FCF Margin Growth (1y) (2012 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 682.00 |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 1.20 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 5,823.00 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -189.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 26,580.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -1.30 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 226,818.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 1,141.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1,854.00 |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -3.65 Mn |
| Mar 31, 2024 | 123,381.00 |
| Dec 31, 2023 | -1.14 Mn |
| Sep 30, 2023 | 27,720.00 |
| Jun 30, 2023 | -705,843.00 |
| Mar 31, 2023 | 88,771.00 |
| Dec 31, 2022 | 98,848.00 |
| Sep 30, 2022 | -62,847.00 |
| Jun 30, 2022 | 391,863.00 |
| Mar 31, 2022 | -75,116.00 |
| Dec 31, 2021 | 361,054.00 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 449,984.00 |
| Mar 31, 2021 | 373,730.00 |
| Dec 31, 2020 | -591,291.00 |
| Sep 30, 2020 | -989,857.00 |
| Jun 30, 2020 | -599,376.00 |
| Mar 31, 2020 | -672,281.00 |
| Dec 31, 2019 | 165,067.00 |
| Sep 30, 2019 | 162,855.00 |